Internal Medicine, Cardiovascular Disease · San Antonio, TX
NPI
1891715769
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
8715 Village Dr Ste 200
San Antonio, TX, 78217
Phone (210) 804-6000
Groups this clinician bills Medicare through
Medicare paid, 2024
$305K
6,167 services
Medicare patients, 2024
1,237
Average age 76
Drug cost, 2024
$1.4M
9,002 prescriptions
Company payments, 2025
$400
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Juan L Garza was code 93000 (electrocardiogram), 1,420 times for 1,086 patients. In total Juan L Garza billed 6,167 services in 42 codes, and Medicare paid $305K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-01-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93000 Electrocardiogram | Office | 1,420 | 1,086 | $9.42 | $13K |
| 99214 Office E&M - Established | Office | 1,109 | 782 | $85.35 | $95K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 756 | 189 | $5.57 | $4,213 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 620 | 512 | $12.35 | $7,660 |
| 99213 Office E&M - Established | Office | 441 | 399 | $54.87 | $24K |
| 93015 Electrocardiogram | Office | 338 | 328 | $47.29 | $16K |
| A9500 Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 235 | 232 | $47.43 | $11K |
| 78452 Myocardial Perfusion Scan | Office | 231 | 231 | $313.48 | $72K |
| 93306 Echocardiography (TTE/TEE) | Office | 229 | 224 | $132.22 | $30K |
| 93294 External Electrocardiographic Monitoring | Office | 127 | 43 | $20.33 | $2,582 |
| 99203 Office E&M - New | Office | 123 | 123 | $71.20 | $8,758 |
| 93298 External Electrocardiographic Monitoring | Office | 92 | 14 | $17.22 | $1,584 |
| 93242 Electrocardiogram | Office | 63 | 60 | $7.42 | $467 |
| 99204 Office E&M - New | Office | 56 | 56 | $113.61 | $6,362 |
| 99215 Office E&M - Established | Office | 43 | 41 | $115.92 | $4,985 |
By year: 2022 $332K for 5,623 services; 2023 $300K for 5,608 services; 2024 $305K for 6,167 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 12 | 11 | $2.97 | $35.58 |
Medicare prescription drug claims, 2024
In 2024, the drug Juan L Garza prescribed most often to Medicare patients was Metoprolol Succinate, with 697 prescriptions and refills. In total Juan L Garza wrote 9,002 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metoprolol Succinate Generic | 697 | 1,985 | 240 | $7,351 |
| Rosuvastatin Calcium Generic | 611 | 1,798 | 199 | $9,885 |
| Telmisartan Generic | 606 | 1,688 | 195 | $14K |
| Atorvastatin Calcium Generic | 585 | 1,721 | 191 | $5,119 |
| Bisoprolol Fumarate Generic | 565 | 1,566 | 188 | $16K |
| Amlodipine Besylate Generic | 560 | 1,607 | 193 | $3,589 |
| Eliquis Apixaban | 504 | 1,155 | 132 | $660K |
| Doxazosin Mesylate Generic | 441 | 1,258 | 141 | $7,168 |
| Carvedilol Generic | 312 | 861 | 102 | $2,590 |
| Lisinopril Generic | 231 | 681 | 81 | $1,537 |
| Losartan Potassium Generic | 203 | 593 | 80 | $1,873 |
| Labetalol Hcl Generic | 187 | 522 | 59 | $3,877 |
| Xarelto Rivaroxaban | 184 | 402 | 49 | $216K |
| Clopidogrel Clopidogrel Bisulfate | 179 | 504 | 64 | $2,367 |
| Amiodarone Hcl Generic | 175 | 498 | 62 | $1,972 |
Brand drugs: - claims; generic drugs: 7,946 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Juan L Garza $400 ($400 in general payments such as food, travel and fees) from 5 companies. The largest payer was Novo Nordisk Inc with $186.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.